Mats Wahlstrom sold Coherus Oncology Inc ($CHRS) shares once on the open market in the last year, totaling about $74,000, with the most recent sale on May 23, 2025. His sales rank 9,967th among 11,678 insiders, well below the average of $8.6 million per person and 6.4 transactions. He made no open market purchases of $CHRS in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Wahlstrom Mats | Director | A | Director Stock Option (right to buy) | 15000 | $0.00 | 200,945.0000 | 32,272,462 | 8.07% | 0.05% |
| June 12, 2025 | Coherus Oncology, Inc. | $CHRS | Wahlstrom Mats | Not found | A | Stock Option (Right to Buy) | 112000 | $0.00 | 112,000.0000 | 115,857,780 | 9999.99% | 0.10% |
| May 23, 2025 | Coherus Oncology, Inc. | $CHRS | Wahlstrom Mats | Not found | S | Common Stock | 99988 | $0.74 | 0.0000 | 115,857,780 | 100.00% | 0.09% |
| Feb. 10, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Wahlstrom Mats | Not found | J | Series A Convertible Preferred Stock | 44750 | $0.00 | 94,750.0000 | 0 | 89.50% | 0.00% |
| Dec. 17, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Wahlstrom Mats | Not found | A | Common Stock | 25188 | $3.97 | 2,665,202.0000 | 0 | 0.95% | 0.00% |
| Nov. 22, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Wahlstrom Mats | Not found | P | Common Stock | 5000 | $4.55 | 2,640,014.0000 | 0 | 0.19% | 0.00% |
| Nov. 20, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Wahlstrom Mats | Not found | P | Common Stock | 2040 | $4.16 | 2,626,327.0000 | 0 | 0.08% | 0.00% |
| Nov. 21, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Wahlstrom Mats | Not found | P | Common Stock | 8687 | $4.44 | 2,635,014.0000 | 0 | 0.33% | 0.00% |
| Aug. 13, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Wahlstrom Mats | Not found | A | Director stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | Coherus Oncology, Inc. | $CHRS | Wahlstrom Mats | Not found | A | Stock Option (Right to Buy) | 112000 | $0.00 | 112,000.0000 | 112,749,306 | 9999.99% | 0.10% |
| Feb. 9, 2024 | Coherus Oncology, Inc. | $CHRS | Wahlstrom Mats | Not found | G | Common Stock | 99988 | $0.00 | 99,988.0000 | 94,162,637 | 9999.99% | 0.11% |
| Feb. 9, 2024 | Coherus Oncology, Inc. | $CHRS | Wahlstrom Mats | Not found | G | Common Stock | 99988 | $0.00 | 99,988.0000 | 94,162,637 | 50.00% | 0.11% |
| Feb. 1, 2024 | Coherus Oncology, Inc. | $CHRS | Wahlstrom Mats | Not found | M | Stock Option (Right to Buy) | 44991 | $0.00 | 0.0000 | 94,162,637 | 100.00% | 0.05% |
| Feb. 1, 2024 | Coherus Oncology, Inc. | $CHRS | Wahlstrom Mats | Not found | M | Common Stock | 14997 | $1.67 | 54,997.0000 | 94,162,637 | 37.49% | 0.02% |
| Feb. 1, 2024 | Coherus Oncology, Inc. | $CHRS | Wahlstrom Mats | Not found | M | Stock Option (Right to Buy) | 14997 | $0.00 | 0.0000 | 94,162,637 | 100.00% | 0.02% |
| Feb. 1, 2024 | Coherus Oncology, Inc. | $CHRS | Wahlstrom Mats | Not found | M | Common Stock | 44991 | $1.67 | 99,988.0000 | 94,162,637 | 81.81% | 0.05% |